Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Anabio Technologies Limited maintains a portfolio in the Chemistry & Materials technology area with 2 pending office actions. These actions are currently assigned to 2 distinct examiners, showing that the company's legal matters are not concentrated under a single individual. Furthermore, the work is divided among 2 distinct art units, which suggests the underlying technologies may involve different specialized classifications within the broader chemistry field.
The busiest examiner identified in the data is LI, CHANGQING. This specific examiner is currently overseeing 1 pending office action for the company. Because there are 2 pending office actions in total, LI, CHANGQING is managing 1 of the active prosecution matters for Anabio Technologies Limited. The distribution across 2 distinct art units and 2 distinct examiners implies that the company must navigate different examination styles and departmental standards simultaneously.
Practitioners should note that with 1 pending action assigned to the busiest examiner, the other action is handled by a different examiner. This distribution of 2 pending actions across 2 distinct examiners reflects a decentralized prosecution environment for the current cases. Monitoring the specific requirements of both distinct art units will be necessary to ensure consistent results across the Chemistry & Materials portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LI, CHANGQING | 1 | 29.6% | +33.1% |
| STEINKE, SEAN JAMES | 1 | 11.8% | +43.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18096404 | SOLUTION OF DENATURED PEA PROTEIN, AND USES THEREOF TO FORM MICROPARTICLES | LI, CHANGQING | 91d overdue |
| 17801079 | COATED MICROCAPSULES AND METHODS FOR THE PRODUCTION THEREOF | STEINKE, SEAN JAMES | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18096404 | SOLUTION OF DENATURED PEA PROTEIN, AND USES THEREOF TO FORM MICROPARTICLES | LI, CHANGQING | 91d overdue |
| 17801079 | COATED MICROCAPSULES AND METHODS FOR THE PRODUCTION THEREOF | STEINKE, SEAN JAMES | — |
| Art Unit | Apps |
|---|---|
| 1791 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18096404 | SOLUTION OF DENATURED PEA PROTEIN, AND USES THEREOF TO FORM MICROPARTICLES | LI, CHANGQING | 1791 | §103§112 | Final Rejection | 91d overdue | Pending | Jan 12, 2023 |
| 17801079 | COATED MICROCAPSULES AND METHODS FOR THE PRODUCTION THEREOF | STEINKE, SEAN JAMES | 1619 | §103§112 | Non-Final OA | — | Pending | Aug 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAnabio Technologies Limited has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Changqing Li has the most, with 1 of Anabio Technologies Limited's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.